Medicamen Organics Financials

NSE: MEDIORG

₹26.75

₹0.00 (0.00%)

As on 16-Oct-2026IST

Market cap

₹40 Cr

Revenue (TTM)

₹23 Cr

P/E Ratio

--

P/B Ratio

1.3

Div. Yield

0 %

Income Statement (₹ Cr)	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Operating Revenue	22.63	38.19	25.27	--	--	--
Total Income	22.71	38.28	26.34	--	--	--
Total Expenditure	26.25	31.57	20.53	--	--	--
EBITDA	-3.62	6.62	4.74	--	--	--
Depreciation	0.90	0.74	0.72	--	--	--
EBIT	-4.52	5.88	4.02	--	--	--
Interest	0.84	0.54	0.65	--	--	--
Other Income	0.08	0.10	1.07	--	--	--
Exceptional Items	--	--	--	--	--	--
Profit before Tax	-5.28	5.43	4.44	--	--	--
Provision for Tax	-1.26	1.38	1.81	--	--	--
Profit after Tax	-4.02	4.05	2.62	--	--	--
Minority Interest	--	--	--	--	--	--
Share of Associate	--	--	--	--	--	--
Consolidated Profit	-4.02	4.05	2.62	--	--	--

Liabilities (₹ Cr)	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Shareholder's Funds	28.73	30.13	15.26	--	--	--
Minority Interest	-0.14	0.35	--	--	--	--
Non-Current Liabilities	1.19	1.57	1.56	--	--	--
Current Liabilities	21.75	27.16	21.62	--	--	--
Total Liabilities	51.63	59.21	38.44	--	--	--

Assets (₹ Cr)	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Non-Current Assets	14.67	13.78	11.13	--	--	--
Current Assets	36.86	45.43	27.31	--	--	--
Total Assets	51.63	59.21	38.44	--	--	--
Total Debt*	14.29	12.35	12.66	--	--	--
Net Current Assets	15.11	18.28	5.69	--	--	--
Contingent Liabilities	0.96	2.46	2.01	--	--	--

Cashflow (₹ Cr)	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Cash From Operating Activities	-4.60	-4.54	-3.66	--	--	--
Cash Flow from Investing Activities	-1.72	-2.35	-0.34	--	--	--
Cash from Financing Activities	3.48	10.47	4.01	--	--	--
Net Cash Inflow / Outflow	-2.83	3.58	0.01	--	--	--

Financials Ratios	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Adjusted EPS (₹)	-3.30	3.46	3.05	--	--	--
Cash EPS (₹)	-2.57	4.09	3.89	--	--	--
Adjusted Book Value (₹)	23.61	25.11	17.74	--	--	--
Dividend per Share (₹)	--	--	--	--	--	--
Cash Flow per Share (₹)	-3.78	-3.88	-4.26	--	--	--
Free Cash Flow per Share (₹)	-4.63	-7.43	-6.08	--	--	--

Profitability Ratios	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
ROCE (%)	-10.38	16.97	18.21	--	--	--
ROE (%)	-13.83	18.13	17.20	--	--	--
ROA (%)	-7.26	8.29	6.83	--	--	--
EBIT Margin (%)	-19.96	15.39	15.90	--	--	--
Net Margin (%)	-17.70	10.57	9.96	--	--	--
Cash Profit Margin (%)	-13.80	12.53	13.23	--	--	--

Growth Ratios	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Revenue Growth (%)	-40.74	51.11	--	--	--	--
EBIT Growth (%)	-176.84	46.30	--	--	--	--
Net Profit Growth (%)	-199.32	54.22	--	--	--	--
EPS Growth (%)	-195.51	13.36	--	--	--	--
Book Value Growth (%)	-2.22	92.53	--	--	--	--

Valuation Ratios	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Price / Earnings	--	6.27	--	--	--	--
Price / Book Value	0.89	0.86	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-10.92	5.01	3.57	--	--	--
Close Price (₹)	21.10	21.70	--	--	--	--
High Price (₹)	49.70	159.40	--	--	--	--
Low Price (₹)	20.05	19.60	--	--	--	--
Market Cap (₹ Cr)	25.67	25.39	--	--	--	--

Solvency Ratios	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Debt to Equity	0.50	0.42	0.83	--	--	--
Short term debt to equity ratio	0.46	0.40	0.81	--	--	--
Current Ratio	1.69	1.67	1.26	--	--	--
Quick Ratio	1.21	1.40	0.98	--	--	--
Interest Coverage	-5.29	11.00	7.85	--	--	--

Operating Efficiency Ratios	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Debtors to sales (%)	82.30	67.70	66.08	--	--	--
Asset Turnover	0.41	0.78	0.66	--	--	--
Receivable days	358.68	203.36	241.20	--	--	--
Inventory Days	145.22	65.15	88.72	--	--	--
Payable days	384.50	286.71	281.84	--	--	--
Cash Conversion Cycle	119.39	-18.20	48.07	--	--	--